Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience?


CRISPR Therapeutics (NASDAQ: CRSP) focuses on modifying DNA. Twist Bioscience (NASDAQ: TWST) focuses on making DNA. Both companies' technologies appear to have tremendous potential. But which is the better biotech stock to buy? That's the question that Motley Fool contributors Keith Speights and Brian Orelli address in this Motley Fool Live video recorded on Jan. 19

Continue reading


Source Fool.com

Like: 0
Share

Comments